Apr Applied Pharma Research Sa

Sigma-tau Industrie Farmaceutiche Riunite S.p.a.

Crinos Industria Farmacobiologica S.p.a.

Jago Research Ag

Neopharmed S.p.a.

Kowa Pharmaceuticals America, Inc.

D and D S.r.l.

Fidia Farmaceutici S.p.a.

Marxer S.p.a.

Proethic Pharmaceuticals, Inc.

Kowa Pharmaeuticals America, Inc.

Ipsen Spa

Wilton Licensing, Ag

Laboratori Prophin S.p.a.

Crinos Farmacologica Spa

Alberto Reiner

Giorgio Reiner

Andreas Meyer

Paolo Colombo

Ubaldo Conte

Paola Maffei

Jacques Gonella

Alessandro Seneci

William R Maichle

Carl L Whatley, Jr

Giacinto Rossi

Norman D Schellenger

Methods and formulations of modified release amino acids are provided for the treatment or management of diseases defined by impaired amino acid metabolism, with improved pharmacokinetics, metabolism and utilization.

Modified release orally administered amino acid formulations

Ready to use liquid formulations of diclofenac potassium are disclosed which are particularly well suited for packaging in stick-packs.

Ready to use diclofenac stick packs

Methods of normalizing amino acid metabolism in subjects on restricted protein diets and supplemental amino acids, using specially formulated amino acids that mimic the absorption and metabolism of naturally occurring proteins, are described.

Methods of normalizing amino acid metabolism

Provided are orally formulations of diclofenac potassium with improved stability in response to cold conditions, and excellent taste and palatability.

Substantially sodium free diclofenac potassium oral solutions

Methods and formulations are provided for treating migraine and other acute pain episodes using diclofenac, and formulations of diclofenac that provide both rapid and sustained relief from acute pain. Methods and formulations are also provided for treating symptoms that often accompany migraine and acute pain such as photophobia, phonophobia, nausea and vomiting.

Diclofenac formulations and methods of use

Provided are rapidly bioavailable solid oral dosage forms of acute pain medications, and moisture resistant packaging that enables the formulation of such rapidly bioavailable dosage forms.

Moisture resistant container systems for rapidly bioavailable dosage forms

A device and composition for delivering menthol, camphor, eucalyptus essential oils, and other essential oils with balsamic benefits, to be used for the relief of symptoms of common cold.

Device and composition for the delivery of a preservative-free balsamic cream

Provided are rapidly bioavailable solid oral dosage forms of acute pain medications, and moisture resistant packaging that enables the formulation of such rapidly bioavailable tablet dosage forms. Also provided is packaging that discourages the use of rapidly bioavailable acute pain medications for off-label chronic pain treatment, and that allows such dosage forms to be manufactured and stored for prolonged periods of time.

Blister packaging for acute pain regimens

Growing community of inventors

Como, Italy

Alberto Reiner